MedComm – Oncology is a peer-reviewed english-language open-access journal published by Wiley in Australia, operating under an open-access model since 2022. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in MedComm – Oncology; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, MedComm – Oncology has published 178 articles. Articles are minted with DOIs through the prefix 10.1002. All submissions undergo plagiarism screening before peer review.
Keywords
cancer, gene therapy, cancer metabolism, immunotherapy, cancer biomarkers
At a glance
- Publisher
- Wiley
- Country
- Australia
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2022
- Review time
- 15 weeks
- DOI prefix
10.1002- Plagiarism check
- Yes
ISSN
- electronic
- 2769-6448
Frequently asked questions
Is MedComm – Oncology peer-reviewed?
Does MedComm – Oncology charge an article processing charge (APC)?
What subjects does MedComm – Oncology publish?
What languages does MedComm – Oncology accept?
What is the ISSN of MedComm – Oncology?
2769-6448 (electronic).